Physiological Finding in Management of COVID 19 Patients

NCT07504341 | Recruiting DMC

• 1 other identifier: 26B-005
• Study Type: observational
• Target: 15,000
• Locations: 1 country
• Sites: 2

Brief Summary

This study utilizes physiological indicators of COVID-19 patients as tools for assessing, tracking, worsening, and improving the clinical symptoms of COVID-19 patients. This study employs simple and easy-to-use assessment methods, which can be further aided by artificial intelligence technology to facilitate early response and medication.

Conditions

COVID-19 (Coronavirus Disease 2019)

Keywords

COVID-19; shock index; mordified shock index; Age shock index; respiratory adjusted shock index

Outcome Measures

Primary Outcomes (4)

• Shock index(SI) in the management of COVID -19

  SI= heart rate / systolic blood pressre

  2022 May to 2027 March

• Mordified shock index(MSI) in the management of COVID -19

  MSI=heart rate / mean arterial pressure

  2022 May to 2027 March

• Age shock index(Age SI) in the management of COVID -19

  Age shock index =Age x (heart rate / systolic blood pression)

  2022 May to 2027 March

• Respiratory adjusted shock index (RASI) in the management of COVID-19

  Respiratory adjusted shock index =(heart rate/systolic blood pression) x (repiratory rate/10)

  2022 may to 2027 March

Study Arms (1)

COVID-19 patient

The COVID-19 patients were devided into admission ,OPD groups

Other: physiological parameters

Interventions

physiological parameters OTHER

systolic blood pressure, diastolic blood pressure , heart rate, respiratory rate , GCS

COVID-19 patient

Eligibility Criteria

• Sex: all
• Healthy Volunteers: No
• Age Groups: Child (0-17), Adult (18-64), Older Adult (65+)
• Sampling Method: Non-Probability Sample

Study Population

The COVID-19 patient received treatment at the hospital between May 2022 and March 2027 from emergency room, OPD

You may qualify if:

• Reviewing the patient's medical history, the primary focus was on hospital records and existing physiological parameters such as blood pressure, heart rate, respiratory rate, and level of consciousness. The patient received treatment at the hospital between May 2022 and March 2027

You may not qualify if:

• Excluding patients with incomplete clinical data or missing information in their medical records.

Sponsors & Collaborators

• St. Martin De Porress Hospital: lead

Study Sites (2)

St. Martin De Porres Hospital

Chiayi City, 60069, Taiwan

RECRUITING

St. Martin De Porres Hospital

Tainan, 60069, Taiwan

RECRUITING

MeSH Terms

Conditions

COVID-19

Condition Hierarchy (Ancestors)

Pneumonia, Viral; Pneumonia; Respiratory Tract Infections; Infections; Virus Diseases; Coronavirus Infections; Coronaviridae Infections; Nidovirales Infections; RNA Virus Infections; Lung Diseases; Respiratory Tract Diseases

Study Officials

• Chia-Hsi Chen, Physician

  St. Martin De Porress Hospital

  PRINCIPAL INVESTIGATOR

Central Study Contacts

Chia-Hsi Chen, Physician

CONTACT

886-5-2756000; urologist3509@gmail.com

Chia-Hsi Chen

CONTACT

886-5-2756000; urologist3509@gmail.com

Study Design

• Study Type: observational
• Observational Model: CASE CONTROL
• Time Perspective: RETROSPECTIVE
• Sponsor Type: OTHER
• Responsible Party: PRINCIPAL INVESTIGATOR
• PI Title: Physician Emergency Medicine and Critical Medicine

Study Record Dates

• First Submitted: March 16, 2026
• First Posted: March 31, 2026
• Study Start: April 1, 2026
• Primary Completion (Estimated): March 11, 2027
• Study Completion (Estimated): March 31, 2027
• Last Updated: March 31, 2026

Record last verified: 2026-03

Data Sharing

• IPD Sharing: Will not share

Locations

TW (2)